2026. Bispecific T-Cell Engager Therapy in Relapsed Acute Lymphoblastic Leukemia: A Review of Published Cohorts. Annals of Leukemia Research. 7, 1 (Aug. 2026), 13–18. DOI:https://doi.org/10.5281/zenodo.22247744.